Vor Biopharma
VOR
VOR
80 hedge funds and large institutions have $717M invested in Vor Biopharma in 2026 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 26 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
45% more funds holding
Funds holding: 55 → 80 (+25)
73% less call options, than puts
Call options by funds: $919K | Put options by funds: $3.41M
Holders
80
Holding in Top 10
6
Calls
$919K
Puts
$3.41M
Top Buyers
| 1 | +$80M | |
| 2 | +$16.3M | |
| 3 | +$15.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$14.5M |
| 5 |
CP
Caligan Partners
New York
|
+$14.1M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$4.02M | |
| 3 | -$3.02M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.13M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.25M |
